- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Celcuity LLC (CELC)
Celcuity LLC stock price live, this page displays NASDAQ CELC stock exchange data. View the CELC premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Celcuity LLC real time stock price chart below.
What Is the Celcuity LLC Stock Price Today?
The Celcuity LLC stock price today is 42.66.
What Is the Stock Symbol for Celcuity LLC?
The stock symbol for Celcuity LLC is ""CELC.""
What Stock Exchange Does Celcuity LLC Trade On?
Celcuity LLC is listed and trades on the NASDAQ stock exchange.
Is Celcuity LLC a Good Stock to Buy?
Determining whether Celcuity LLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CELC quote. (ISIN: US15102K1007)
What Is the Celcuity LLC Stock Price Today?
The Celcuity LLC stock price today is 42.66.
What Is the Stock Symbol for Celcuity LLC?
The stock symbol for Celcuity LLC is ""CELC.""
What Stock Exchange Does Celcuity LLC Trade On?
Celcuity LLC is listed and trades on the NASDAQ stock exchange.
Is Celcuity LLC a Good Stock to Buy?
Determining whether Celcuity LLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CELC quote. (ISIN: US15102K1007)
NASDAQ
Currency in USD
42.66
-0.47(-1.09%)
Real-time Data·
Fair Value
An estimate of a Celcuity's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
42.28
44.24
52 wk Range
7.58
46.42
CELC Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
CELC is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Celcuity's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
42.2844.24
52 wk Range
7.5846.42
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CELC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Celcuity's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
60.86
Upside
+42.66%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
- Form 8K Celcuity LLC For: 29 July
- Investing.com
- Celcuity receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Celcuity LLC Company Profile
Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company’s lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2 to treat patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) or HR+/HER2-, advanced or metastatic breast cancer (ABC), and patients with metastatic castration resistant prostate cancer (mCRPC). It also engages in developing of CELsignia diagnostic platform. The company had a license agreement with Pfizer Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was founded in 2011 and is based in Minneapolis, Minnesota.
Celcuity LLC Earnings Call Summary for Q1/2025
- Celcuity reports Q1 2025 EPS of -$0.86, missing -$0.72 forecast; stock stable at $10.86 in aftermarket trading
- Net loss widens to $37M from $21.6M YoY; R&D expenses increase to $32.2M from $20.6M
- Strong cash position of $205.7M expected to fund operations through 2026
- Top-line data from key clinical trials anticipated in Q3 and Q4 2025; prostate cancer trial results expected late Q2 2025
- CEO highlights potential of gadotelisib as new standard of care in combination therapy for cancer treatment
Last Updated: 14/05/2025, 22:24
Read Full TranscriptCompare CELC to Peers and Sector
Metrics to compare | CELC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCELCPeersSector | |
|---|---|---|---|---|
P/E Ratio | −14.0x | −3.5x | −0.5x | |
PEG Ratio | 1.33 | −0.01 | 0.00 | |
Price/Book | 20.6x | 2.3x | 2.6x | |
Price / LTM Sales | - | 10.3x | 3.3x | |
Upside (Analyst Target) | 39.2% | 185.8% | 43.5% | |
Fair Value Upside | Unlock | 0.3% | 6.3% | Unlock |
Analyst Ratings
8 Buy
0 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 60.86
(+42.66% Upside)
Earnings
Latest Release
May 14, 2025
EPS / Forecast
-0.86 / -0.72
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Celcuity Trade On?
Celcuity is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Celcuity?
The stock symbol for Celcuity is "CELC."
What Is the Celcuity Market Cap?
As of today, Celcuity market cap is 1.74B.
What Is Celcuity's Earnings Per Share (TTM)?
The Celcuity EPS (TTM) is -3.04.
When Is the Next Celcuity Earnings Date?
Celcuity will release its next earnings report on 06 Aug 2025.
From a Technical Analysis Perspective, Is CELC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Celcuity Stock Split?
Celcuity has split 0 times.
How Many Employees Does Celcuity Have?
Celcuity has 87 employees.
What is the current trading status of Celcuity (CELC)?
As of 05 Aug 2025, Celcuity (CELC) is trading at a price of 42.66, with a previous close of 43.13. The stock has fluctuated within a day range of 42.28 to 44.24, while its 52-week range spans from 7.58 to 46.42.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.